Back to Search Start Over

Image-Based Identification and Genomic Analysis of Single Circulating Tumor Cells in High Grade Serous Ovarian Cancer Patients.

Authors :
Salmon C
Levermann J
Neves RPL
Liffers ST
Kuhlmann JD
Buderath P
Kimmig R
Kasimir-Bauer S
Source :
Cancers [Cancers (Basel)] 2021 Jul 26; Vol. 13 (15). Date of Electronic Publication: 2021 Jul 26.
Publication Year :
2021

Abstract

In Ovarian Cancer (OC), the analysis of single circulating tumor cells (sCTCs) might help to investigate genetic tumor evolution during the course of treatment. Since common CTC identification features failed to reliably detect CTCs in OC, we here present a workflow for their detection and genomic analysis. Blood of 13 high-grade serous primary OC patients was analyzed, using negative immunomagnetic enrichment, followed by immunofluorescence staining and imaging for Hoechst, ERCC1, CD45, CD11b and cytokeratin (CK) and sCTC sorting with the DEPArray <superscript>TM</superscript> NxT. The whole genome of single cells was amplified and profiled for copy number variation (CNV). We detected: Type A-cells, epithelial (Hoechst <superscript>pos</superscript> , ERCC1 <superscript>pos</superscript> , CD45 <superscript>neg</superscript> , CD11b <superscript>pos</superscript> , CK <superscript>pos</superscript> ); Type B-cells, potentially epithelial (Hoechst <superscript>pos</superscript> , ERCC1 <superscript>pos</superscript> , CD45 <superscript>neg</superscript> , CD11b <superscript>pos</superscript> , CK <superscript>neg</superscript> ) and Type C-cells, potentially mesenchymal (Hoechst <superscript>pos</superscript> , ERCC1 <superscript>pos</superscript> , CD45 <superscript>neg</superscript> , CD11b <superscript>neg</superscript> , CK <superscript>neg</superscript> ). In total, we identified five (38.5%) patients harboring sCTCs with an altered CN profile, which were mainly Type A-cells (80%). In addition to inter-and intra-patient genomic heterogeneity, high numbers of Type B- and C-cells were identified in every patient with their aberrant character only confirmed in 6.25% and 4.76% of cases. Further identification markers and studies in the course of treatment are under way to expand sCTC analysis for the identification of tumor evolution in OC.

Details

Language :
English
ISSN :
2072-6694
Volume :
13
Issue :
15
Database :
MEDLINE
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
34359649
Full Text :
https://doi.org/10.3390/cancers13153748